The US Food and Drug Administration's emergency use authorization of Pfizer and BioNTech's coronavirus vaccine is a crucial step in developing the new-generation vaccine, BioNTech CEO Ugur Sahin says.
//google call
The US Food and Drug Administration's emergency use authorization of Pfizer and BioNTech's coronavirus vaccine is a crucial step in developing the new-generation vaccine, BioNTech CEO Ugur Sahin says.
0 comments:
Post a Comment